Telemus Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Telemus Capital’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,000	Closed	-$1.87M	–	457
2020 Q3	$1.87M	Hold	17,000	–	–	0.14%	130
2020 Q2	$1.59M	Hold	17,000	–	–	0.13%	135
2020 Q1	$1.76M	Hold	17,000	–	–	0.14%	122
2019 Q4	$1.89M	Hold	17,000	–	–	0.15%	120
2019 Q3	$1.69M	Hold	17,000	–	–	0.14%	126
2019 Q2	$1.62M	Hold	17,000	–	–	0.14%	123
2019 Q1	$1.88M	Hold	17,000	–	–	0.14%	124
2018 Q4	$1.56M	Hold	17,000	–	–	0.13%	128
2018 Q3	$1.87M	Hold	17,000	–	–	0.14%	124
2018 Q2	$1.59M	Hold	17,000	–	–	0.12%	144
2018 Q1	$1.41M	Hold	17,000	–	–	0.11%	161
2017 Q4	$1.55M	Hold	17,000	–	–	0.12%	149
2017 Q3	$1.29M	Hold	17,000	–	–	0.15%	109
2017 Q2	$1.27M	Sell	17,000 -3,000	-15%	-$208K	0.13%	133
2017 Q1	$1.3M	Hold	20,000	–	–	0.14%	127
2016 Q4	$1.1M	Buy	+20,000	New	+$1.1M	0.15%	116

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Telemus Capital's PRAH Position: Q4 2020 in Review

Telemus Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2020, closing a stake of 17,000 shares — an estimated $1.87M sold.

Telemus Capital first reported a position in PRAH in Q4 2016 and held it in 16 quarters. The position peaked at $1.89M in Q4 2019. 289 funds tracked by Wall St. Rank hold PRAH as of Q4 2020.

Telemus Capital reported no remaining PRA Health Sciences, Inc. position as of Q4 2020 after selling out during the quarter.
Telemus Capital sold 17,000 PRA Health Sciences, Inc. shares in Q4 2020, an estimated $1.87M.
Telemus Capital first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 16 quarters.
Telemus Capital's PRA Health Sciences, Inc. position peaked at $1.89M in Q4 2019.
289 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2020.

Based on Telemus Capital's 13F filing for Q4 2020, filed 28 Jan 2021.